Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of rat nerve growth factor injection for optic nerve injury
ChiCTR-TRC-13004103Phase 3Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of rat nerve growth factor in Optic neuropathies (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Best corrected visual acuity and Effect scores. Started Dec 2013; status: completed.
02
Drugs
rat nerve growth factor
03
Conditions
Optic neuropathies
Beyond the preview
Go deeper on ChiCTR-TRC-13004103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13004103.